21 - 30 out of 56Page size: 10
  1. 2022

  2. Design and Evaluation of Bispidine-Based SARS-CoV-2 Main Protease Inhibitors

    Shcherbakov, D., Baev, D., Kalinin, M., Dalinger, A., Chirkova, V., Belenkaya, S., Khvostov, A., Krut'Ko, D., Medved'Ko, A., Volosnikova, E., Sharlaeva, E., Shanshin, D., Tolstikova, T., Yarovaya, O., Maksyutov, R., Salakhutdinov, N. & Vatsadze, S., 13 Jan 2022, In: ACS Medicinal Chemistry Letters. 13, 1, p. 140-147 8 p.

    Research output: Contribution to journal › Article › peer-review

  3. Synthesis and In Vitro Study of Antiviral Activity of Glycyrrhizin Nicotinate Derivatives against HIV-1 Pseudoviruses and SARS-CoV-2 Viruses

    Fomenko, V. V., Rudometova, N. B., Yarovaya, O. I., Rogachev, A. D., Fando, A. A., Zaykovskaya, A. V., Komarova, N. I., Shcherbakov, D. N., Pyankov, O. V., Pokrovsky, A. G., Karpenko, L. I., Maksyutov, R. A. & Salakhutdinov, N. F., 1 Jan 2022, In: Molecules. 27, 1, 295.

    Research output: Contribution to journal › Article › peer-review

  4. 2021

  5. Dehydroabietylamine-based thiazolidin-4-ones and 2-thioxoimidazolidin-4-ones as novel tyrosyl-DNA phosphodiesterase 1 inhibitors

    Kovaleva, K., Mamontova, E., Yarovaya, O., Zakharova, O., Zakharenko, A., Lavrik, O. & Salakhutdinov, N., Nov 2021, In: Molecular Diversity. 25, 4, p. 2389-2397 9 p.

    Research output: Contribution to journal › Article › peer-review

  6. Stability study of the antiviral agent camphecene in dried blood spots at different temperatures

    Okhina, A. A., Rogachev, A. D., Yarovaya, O. I., Pokrovsky, A. G. & Salakhutdinov, N. F., Oct 2021, In: Drug Testing and Analysis. 13, 10, p. 1797-1802 6 p.

    Research output: Contribution to journal › Letter › peer-review

  7. Biostability study, quantitation method and preliminary pharmacokinetics of a new antifilovirus agent based on borneol and 3-(piperidin-1-yl)propanoic acid

    Rogachev, A. D., Putilova, V. P., Zaykovskaya, A. V., Yarovaya, O. I., Sokolova, A. S., Fomenko, V. V., Pyankov, O. V., Maksyutov, R. A., Pokrovsky, A. G. & Salakhutdinov, N. F., 30 May 2021, In: Journal of Pharmaceutical and Biomedical Analysis. 199, 114062.

    Research output: Contribution to journal › Article › peer-review

  8. Design, synthesis, and molecular docking study of new tyrosyl-dna phosphodiesterase 1 (Tdp1) inhibitors combining resin acids and adamantane moieties

    Kovaleva, K., Yarovaya, O., Ponomarev, K., Cheresiz, S., Azimirad, A., Chernyshova, I., Zakharenko, A., Konev, V., Khlebnikova, T., Mozhaytsev, E., Suslov, E., Nilov, D., Švedas, V., Pokrovsky, A., Lavrik, O. & Salakhutdinov, N., 1 May 2021, In: Pharmaceuticals. 14, 5, 422.

    Research output: Contribution to journal › Article › peer-review

  9. Unexpected Ring Opening During the Imination of Camphor-Type Bicyclic Ketones

    Chernyshov, V. V., Yarovaya, O. I., Vatsadze, S. Z., Borisevich, S. S., Trukhan, S. N., Gatilov, Y. V., Peshkov, R. Y., Eltsov, I. V., Martyanov, O. N. & Salakhutdinov, N. F., 22 Jan 2021, In: European Journal of Organic Chemistry. 2021, 3, p. 452-463 12 p.

    Research output: Contribution to journal › Article › peer-review

  10. 2020

  11. Monoterpenoid-based inhibitors of filoviruses targeting the glycoprotein-mediated entry process

    Sokolova, A. S., Yarovaya, O. I., Zybkina, A. V., Mordvinova, E. D., Shcherbakova, N. S., Zaykovskaya, A. V., Baev, D. S., Tolstikova, T. G., Shcherbakov, D. N., Pyankov, O. V., Maksyutov, R. A. & Salakhutdinov, N. F., 1 Dec 2020, In: European Journal of Medicinal Chemistry. 207, 17 p., 112726.

    Research output: Contribution to journal › Article › peer-review

  12. New chemical agents based on adamantane-monoterpene conjugates against orthopoxvirus infections

    Suslov, E. V., Mozhaytsev, E. S., Korchagina, D. V., Bormotov, N. I., Yarovaya, O. I., Volcho, K. P., Serova, O. A., Agafonov, A. P., Maksyutov, R. A., Shishkina, L. N. & Salakhutdinov, N. F., Oct 2020, In: RSC Medicinal Chemistry. 11, 10, p. 1185-1195 11 p.

    Research output: Contribution to journal › Article › peer-review

  13. 1,1’-(Гексан-1,6-диил)бис(3-(((1R,4aS,10aR)-7-изопропил-1,4a-диметил-1,2,3,4,4a,9,10,10a-октагидрофенантрен-1-ил)метил)мочевина, проявляющая ингибирующее действие в отношении фермента тирозил-ДНК-фосфодиэстеразы 1 человека и увеличивающая активность темозоломида в отношении клеток глиобластомы

    Ковалева, К. С., Олешко, О. С., Яровая, О. И., Мамонтова, Е. М., Захаренко, А. Л., Захарова, О. Д., Чересиз, С. В., Покровский, А. Г., Лаврик, О. И. & Салахутдинов, Н. Ф., 26 Jun 2020, IPC No. C07C275/24, A61K31/17, A61P35/00, Роспатент - Федеральная служба по интеллектуальной собственности, Patent No. 2724882, Priority date 28 Nov 2019, Priority No. 2019138671

    Research output: Patent › Patent for invention

Previous 1 2 3 4 5 6 Next

ID: 3449511